Lacosamide Tablet, Film Coated
Product Images NDC 67877-736

8 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 67877-736). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Laco-str (Laco Str)

Laco-str (Laco Str)
Chemical structure of lacosamide, the active ingredient in the product Lacosamide. The diagram shows the molecular arrangement including functional groups such as an amide, an ether, and a benzyl group.*
FDA Label Image

Laco-fig1.jpg (Laco Fig1)

Laco-fig1.jpg (Laco Fig1)
A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' comparing seizure reduction percentages between placebo and various doses of Lacosamide across three studies. The vertical axis shows median seizure reduction percentages from 0% to 45%, and the horizontal axis categorizes placebo and Lacosamide doses (200 mg, 400 mg, 600 mg). Each study is presented separately, with Lacosamide doses generally showing higher median seizure reductions than placebo, some marked as statistically significant.*
FDA Label Image

Laco-fig2.jpg (Laco Fig2)

Laco-fig2.jpg (Laco Fig2)
A line graph titled 'Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4' showing responder rates on the vertical axis (from -100% worsening to 100% improvement) versus percent of patients on the horizontal axis (100% to 0%). It compares placebo (N=359) with three doses of lacosamide: 200 mg/day (N=267), 400 mg/day (N=466), and 600 mg/day (N=202), illustrating differences in responder rates across patient percentages.*
FDA Label Image

Laco-fig3-a (Laco Fig3 A)

Laco-fig3-a (Laco Fig3 A)
A survival curve chart showing the proportion of patients over time (in days) comparing Lacosamide and placebo groups. The chart includes a risk table below with patient counts for each group at various time points and statistical values including p-value, hazard ratio, and confidence interval.*
FDA Label Image

Laco-cont50 (Laco Cont50)

Laco-cont50 (Laco Cont50)
Label for Lacosamide Tablets USP, 50 mg film-coated oral tablets, distributed by Ascend Laboratories, LLC. The label includes the NDC 67877-733-60 and states each tablet contains 50 mg lacosamide. It advises to store at controlled room temperature and notes a total package count of 60 tablets. The label also directs pharmacists to provide the Medication Guide and includes a URL for the guide.*
FDA Label Image

Laco-cont100 (Laco Cont100)

Laco-cont100 (Laco Cont100)
Lacosamide Tablets, USP 100 mg film-coated tablets label showing dosage form and strength. Distributed by Ascend Laboratories, LLC, the label includes storage instructions, manufacturer details (Alkem Laboratories Ltd., India), and a 60-tablet count. The label also features a barcode, NDC 67877-734-60, and a note for pharmacists regarding medication guides.*
FDA Label Image

Laco-cont150 (Laco Cont150)

Laco-cont150 (Laco Cont150)
Lacosamide Tablets, USP 150 mg film-coated oral tablets packaging label showing quantity of 60 tablets. The label includes storage instructions, manufacturer as Alkem Laboratories Ltd., distributor as Ascend Laboratories, LLC, and a barcode. The label also directs pharmacists to provide a medication guide and references a website for the guide.*
FDA Label Image

Laco-cont-200 (Laco Cont 200)

Laco-cont-200 (Laco Cont 200)
Label for Lacosamide Tablets, USP 200 mg, film-coated oral tablets. The label shows the NDC 67877-736-60 and indicates a package size of 60 tablets. It includes storage instructions, manufacturer (Alkem Laboratories Ltd., India), and distributor (Ascend Laboratories, LLC). The label notes that each tablet contains 200 mg lacosamide and includes a caution for pharmacists to provide the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.